Saad, F., Hotte, S. J., Jayaram, A., Artigas, C., Saleh, R., Maurice-Dror, C., Bruwaene, S. V., Boixareu, C., Tunariu, N., Hamilou, Z., Juneau, D., Glaus, C., Walker, K., Wang, Y. (., Griessinger, C. M., Hosein, A. N., Bono, J. S. D. (2026). First-in-human assessment of actinium-225-prostate-specific membrane antigen (
                    <sup>225</sup>
                    Ac-PSMA)-Trillium (BAY 3563254) in mCRPC: Dose-escalation results of the phase 1 PAnTHa study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.19